1Meryer J, Szukies B,Neubauer k, etal. Extracellular matrix proteins as a early markers in diabetic nephropathy 〔J〕. EurJ Clin Chem Clin Biochem, 1995,33:211～215.
2Kreisbery JI, Radmile RA, Ayosh J, et al. High glucose elevates c-fos and c-juntranscripts and proteins in mesangial cell cultures 〔J〕. kidney Int, 1994,45:105～112.
3Eiji Ⅰ, Yoshilci N, shigeichj S. Serum type Ⅲ、Ⅳ collagens and TIMP inpatient with type 2 diabetes mellitus 〔J〕. life Sci, 1996,58:1331～1337.
4Banu U, Hara H, Okarnura M, et al. Urinary excretion of type Ⅳ collagen andlaminin in the evaluation of nephropathy in NIDDM: comparision with urinary albumin andmarkers of tubular dysfunction and/or damage 〔J〕. Diabetes Res Clin Pract, 1995,29:57～67.
5Meyer Ⅱ, Szukics B, Neubauer k, et al. Extracellullar matrix proteins as earlymarkers in diabetic nephropathy 〔J〕. Eur J Clin Chem Clin Biochem, 1995,33:211～219.
6Takahashi M, Dohi N, Nishioka H. Increased urinary fibronectin excertion in typeⅡ diabetie patients with microalbuminuria 〔J〕. Nippon Jinzo Gakkai Shi, 1995,37:336～342.
7Kanauchi M, Nishioka H, Dohi N. Diagnostic significance of urinary fibronectin indiabetic nephropathy 〔J〕. Nippon Jinzo Gakkei Shi, 1995,37:127～133.
8Pichup JC, Mattoch MB, Chusney GD. NIDDM as a disease of the innate immune system:association of acute-phase reactants and interleukin-6 with metabolic syndrome 〔J〕.Diabetologia, 1997,40:1286～1292.
9Pichup TC, Roberts GA, Kehely AM, et al. Higher serum sialic acid in women than inmen with NIDDM: Possible relevance to increased cardiovascular in NIDDM women 〔J〕.Diabetes Care, 1997,20:1496～1507.
10Chen J, Gall MA, Yokoyama H. Raised serum sialic acid concentration in NIDDMpatients with and without diabetic nephropathy 〔J〕. Diabetes Care, 1996,19:130～134.
